Concepedia

V. Blair Journigan

VB

Statistics

Publications

9

Citations

216

H-Index

9

Active since

2014

Affiliations

Astraea Therapeutics (United States)(Current)

SRI International

University of Ferrara

Marshall University

National Institute on Drug Abuse

V. Blair Journigan is an author at Astraea Therapeutics (United States) specializing in pharmacology, receptor pharmacology, and medicine.

ORCID

Publications per year

2014–2021

9

Publications

9

In vitro pharmacological characterization of a novel unbiased <scp>NOP</scp> receptor‐selective nonpeptide agonist <scp>AT</scp>‐403

Federica Ferrari, Davide Malfacini, V. Blair Journigan et al. · Pharmacology Research & Perspectives · 2017 · 31 citations · Full text

, , +17

Nonpeptide Small Molecule Agonist and Antagonist Original Leads for Neuropeptide FF1 and FF2 Receptors

V. Blair Journigan, Christophe Mésangeau, Neha Vyas et al. · Journal of Medicinal Chemistry · 2014 · 29 citations · Full text

, , +17

Designing bifunctional NOP receptor–mu opioid receptor ligands from NOP-receptor selective scaffolds. Part II

V. Blair Journigan, Willma E. Polgar, Taline V. Khroyan et al. · Bioorganic & Medicinal Chemistry · 2014 · 26 citations · Full text

, , +14

Buprenorphine requires concomitant activation of NOP and MOP receptors to reduce cocaine consumption

Marsida Kallupi, Qianwei Shen, Giordano de Guglielmo et al. · Addiction Biology · 2017 · 26 citations · Full text

, , +17

Structure-Based Design of Novel Biphenyl Amide Antagonists of Human Transient Receptor Potential Cation Channel Subfamily M Member 8 Channels with Potential Implications in the Treatment of Sensory Neuropathies

V. Blair Journigan, Zhiwei Feng, S.M. Jamshedur Rahman et al. · ACS Chemical Neuroscience · 2019 · 26 citations · Full text

, , +17

1–5 of 9